Microchip Technology (MCHP) Stock Could Be 8.6% Overvalued After Strait Of Hormuz Deal

Microchip Technology (MCHP) is back in focus after a newly announced Middle East peace deal to reopen the Strait of Hormuz lifted sentiment around industrial and automotive activity tied to its analog and embedded chips.

See our latest analysis for Microchip Technology.

At a share price of US$94.11, Microchip Technology has seen a 7-day share price return of 7.05% and a 90-day share price return of 48.70%. The 1-year total shareholder return of 42.11% points to strong momentum rather than a short spike around the Strait of Hormuz news and the Armenia export license approval.

If this mix of industrial, automotive and FPGA growth stories interests you, it could be a good moment to widen your watchlist with 49 AI infrastructure stocks

After a 90 day run that lifted Microchip Technology stock nearly 49% and a 1 year total return above 42%, the key question for investors is simple: is there still value left here or is the market already pricing in future growth?

Most Popular Narrative: 8.6% Overvalued

The most followed narrative currently pegs Microchip Technology's fair value at $86.67, below the last close of $94.11, which sets up a valuation gap investors need to understand.

Operational leverage is set to improve as inventory write-offs and factory underutilization charges decline, with management targeting a return to 65% non-GAAP gross margins; as factory utilization ramps beginning in the December quarter and charges subside, incremental profits are expected to flow disproportionately to operating income and earnings.

Read the complete narrative.

Want to see what is built into that margin story for Microchip Technology? The narrative focuses on a mix of revenue growth, richer profit margins and a higher future earnings multiple. Curious how those assumptions line up with your own view of the stock's recent surge?

Result: Fair Value of $86.67 (OVERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Microchip Technology still faces pressure from elevated inventories and substantial debt, which could weigh on margins and limit flexibility if conditions do not improve.

Find out about the key risks to this Microchip Technology narrative.

Another View On Microchip Technology Stock

While the narrative driven fair value of US$86.67 suggests Microchip Technology stock is 8.6% overvalued versus the US$94.11 share price, the price to sales ratio tells a slightly different story. MCHP trades at 10.8x sales, above the US Semiconductor industry at 8.6x, but below peers at 21x and close to its 11.9x fair ratio. This points to more balanced valuation risk than the headline fair value gap alone might imply. That mix of signals raises a simple question: which metric do you trust most for a business in the middle of a recovery story?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Reading through the mixed sentiment around Microchip Technology, with both risks and rewards in play, it makes sense to move fast and review the underlying data yourself so you can form a clear view using the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Microchip Technology?

If you stop with Microchip Technology, you could miss other opportunities that fit your style, so widen your search now using these focused stock idea lists.

• Target resilient companies first and reduce portfolio stress by checking out 65 resilient stocks with low risk scores tailored to lower risk profiles.
• Hunt for quality at a reasonable price by scanning 48 high quality undervalued stocks where fundamentals and valuation work together.
• Prioritize financial strength by reviewing the solid balance sheet and fundamentals stocks screener (48 results) and focus on businesses with sturdier foundations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com